<?xml version='1.0' encoding='utf-8'?>
<document id="30556732"><sentence text="Does antagonism at 5-HT2A receptors potentiate D₂ blockade-induced disruption of conditioned avoidance response?" /><sentence text="Existing evidence in the literature shows that antagonism at 5-HT2A receptors potentiates D₂ antagonism-induced disruption of conditioned avoidance response (CAR), a behavioral index of antipsychotic activity, suggesting that combining 5-HT2A antagonism with D₂ antagonism may confer an enhanced antipsychotic effect" /><sentence text=" The present study reexamined this issue and further investigated other behavioral effects of drug-drug interaction, mainly the conditioned drug effect (via drug-drug conditioning) and 5-HT2A antagonism's modulation on antipsychotic-induced sensitization (an enhanced avoidance disruption)" /><sentence text=" Well-trained adult male Sprague-Dawley rats were first repeatedly tested for 7 days under haloperidol (HAL; 0"><entity charOffset="91-102" id="DDI-PubMed.30556732.s4.e0" text="haloperidol" /><entity charOffset="104-107" id="DDI-PubMed.30556732.s4.e1" text="HAL" /><pair ddi="false" e1="DDI-PubMed.30556732.s4.e0" e2="DDI-PubMed.30556732.s4.e0" /><pair ddi="false" e1="DDI-PubMed.30556732.s4.e0" e2="DDI-PubMed.30556732.s4.e1" /></sentence><sentence text="05 mg/kg, subcutaneous [sc], a typical antipsychotic drug with potent D2 antagonism), MDL100907 (0" /><sentence text="5 and 1" /><sentence text="0 mg/kg, sc, a selective 5-HT2A antagonist), combined MDL100907 and HAL, or vehicle control, followed by one challenge test under MDL100907 (0"><entity charOffset="68-70" id="DDI-PubMed.30556732.s7.e0" text="HAL" /></sentence><sentence text="5 mg/kg) to assess the conditioned drug effect and one challenge test under HAL (0"><entity charOffset="76-78" id="DDI-PubMed.30556732.s8.e0" text="HAL" /></sentence><sentence text="025 mg/kg) to assess HAL sensitization"><entity charOffset="21-23" id="DDI-PubMed.30556732.s9.e0" text="HAL" /></sentence><sentence text=" Results showed that MDL100907 by itself had no effect on CAR" /><sentence text=" Importantly, MDL100907 treatment did little to alter the acute and sensitized effects of HAL-induced (0"><entity charOffset="90-92" id="DDI-PubMed.30556732.s11.e0" text="HAL" /></sentence><sentence text="05 mg/kg, sc) suppression of CAR under various treatment conditions" /><sentence text=" Repeated pairing of MDL100907 (1" /><sentence text="0 mg/kg) with HAL rendered MDL100907 itself to exhibit an &quot;acquired&quot; CAR disruptive effect through a drug-drug conditioning process"><entity charOffset="14-16" id="DDI-PubMed.30556732.s14.e0" text="HAL" /></sentence><sentence text=" These results do not support the notion that 5-HT2A receptor blockade enhances the antipsychotic-like effects of typical antipsychotic drugs, although they do highlight the importance of drug-drug conditioning process in altering drug efficacy in polypharmacy" /><sentence text=" (PsycINFO Database Record (c) 2019 APA, all rights reserved)" /><sentence text="" /></document>